Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jack Allen 's Stock Ratings
Baird Analyst
Jack Allen is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
-14.8%
Smart Score
Overall Average Return Percentile
15th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | FATE | Buy Now | Fate Therapeutics | $1.26 | 217.46% | Jack Allen 37% | $5 → $4 | Maintains | Neutral | Get Alert |
| 05/14/2025 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 587.02% | Jack Allen 37% | $12 → $9 | Maintains | Outperform | Get Alert |
| 12/12/2024 | CARM | Buy Now | CARISMA Therapeutics | $0.49 | 104.12% | Jack Allen 37% | $10 → $1 | Downgrade | Outperform → Neutral | Get Alert |
| 11/15/2024 | INKT | Buy Now | MiNK Therapeutics | $7.49 | -46.6% | Jack Allen 37% | $8 → $4 | Maintains | Outperform | Get Alert |
| 11/08/2024 | VOR | Buy Now | Vor Biopharma | $0.22 | 6263.64% | Jack Allen 37% | $22 → $14 | Maintains | Outperform | Get Alert |
| 11/06/2024 | ACLX | Buy Now | Arcellx | $63.82 | 66.09% | Jack Allen 37% | $77 → $106 | Maintains | Outperform | Get Alert |
| 10/25/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 93.55% | Jack Allen 37% | $24 → $18 | Maintains | Neutral | Get Alert |
| 09/16/2024 | TIL | Buy Now | Instil Bio | $28.57 | 530.03% | Jack Allen 37% | $180 → $180 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2024 | TIL | Buy Now | Instil Bio | $28.57 | 530.03% | Jack Allen 37% | $32 → $180 | Maintains | Outperform | Get Alert |
| 08/15/2024 | BLUE | Buy Now | bluebird bio | — | — | Jack Allen 37% | $7 → $6 | Maintains | Outperform | Get Alert |
| 06/13/2024 | MREO | Buy Now | Mereo BioPharma Group | $2.88 | 177.78% | Jack Allen 37% | → $8 | Initiates | → Outperform | Get Alert |
| 05/13/2024 | TIL | Buy Now | Instil Bio | $28.57 | 12.01% | Jack Allen 37% | $54 → $32 | Maintains | Outperform | Get Alert |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $44.48 | 16.91% | Jack Allen 37% | $46 → $52 | Maintains | Neutral | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $63.82 | 20.65% | Jack Allen 37% | $63 → $77 | Maintains | Outperform | Get Alert |
| 01/19/2024 | TIL | Buy Now | Instil Bio | $28.57 | 89.01% | Jack Allen 37% | → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 01/17/2024 | TIL | Buy Now | Instil Bio | $28.57 | 89.01% | Jack Allen 37% | $100 → $54 | Maintains | Outperform | Get Alert |
| 12/12/2023 | BLUE | Buy Now | bluebird bio | — | — | Jack Allen 37% | $10 → $7 | Maintains | Outperform | Get Alert |
| 10/31/2023 | IMCR | Buy Now | Immunocore Hldgs | $31.70 | 164.98% | Jack Allen 37% | → $84 | Initiates | → Outperform | Get Alert |
| 09/26/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jack Allen 37% | $4 → $0.5 | Downgrade | Outperform → Neutral | Get Alert |
| 08/15/2023 | ACLX | Buy Now | Arcellx | $63.82 | -18.52% | Jack Allen 37% | $40 → $52 | Maintains | Outperform | Get Alert |
| 08/15/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.55 | 213.73% | Jack Allen 37% | $6 → $8 | Maintains | Outperform | Get Alert |
| 08/10/2023 | DBTX | Buy Now | Decibel Therapeutics | — | — | Jack Allen 37% | $21 → $5.25 | Downgrade | Outperform → Neutral | Get Alert |
| 06/28/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.49 | 1941.23% | Jack Allen 37% | → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 04/14/2023 | ACLX | Buy Now | Arcellx | $63.82 | -38.89% | Jack Allen 37% | → $39 | Initiates | → Outperform | Get Alert |
| 04/14/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.49 | 1941.23% | Jack Allen 37% | → $10 | Initiates | → Outperform | Get Alert |
| 04/13/2023 | ACLX | Buy Now | Arcellx | $63.82 | -38.89% | Jack Allen 37% | → $39 | Initiates | → Outperform | Get Alert |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $0.22 | 9900% | Jack Allen 37% | $38 → $22 | Maintains | Outperform | Get Alert |
| 03/07/2023 | CRSP | Buy Now | CRISPR Therapeutics | $44.48 | 3.42% | Jack Allen 37% | → $46 | Initiates | → Neutral | Get Alert |
| 03/07/2023 | BLUE | Buy Now | bluebird bio | — | — | Jack Allen 37% | → $10 | Initiates | → Outperform | Get Alert |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 351.61% | Jack Allen 37% | $58 → $42 | Maintains | Neutral | Get Alert |
| 02/14/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jack Allen 37% | $10 → $4 | Maintains | Outperform | Get Alert |
| 02/01/2023 | TSHA | Buy Now | Taysha Gene Therapies | $2.55 | 135.29% | Jack Allen 37% | $10 → $6 | Maintains | Outperform | Get Alert |
| 01/06/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 816.03% | Jack Allen 37% | → $12 | Upgrade | Neutral → Outperform | Get Alert |
| 11/17/2022 | TIL | Buy Now | Instil Bio | $28.57 | -51% | Jack Allen 37% | $24 → $14 | Maintains | Outperform | Get Alert |
| 11/02/2022 | LCTX | Buy Now | Lineage Cell Therapeutics | — | — | Jack Allen 37% | → $5 | Initiates | → Outperform | Get Alert |
| 11/02/2022 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jack Allen 37% | → $10 | Initiates | → Outperform | Get Alert |
| 11/01/2022 | TIL | Buy Now | Instil Bio | $28.57 | -16% | Jack Allen 37% | $31 → $24 | Maintains | Outperform | Get Alert |
| 10/26/2022 | TSHA | Buy Now | Taysha Gene Therapies | $2.55 | 723.53% | Jack Allen 37% | $26 → $21 | Maintains | Outperform | Get Alert |
| 09/13/2022 | RCOR | Buy Now | Renovacor | — | — | Jack Allen 37% | → $9 | Initiates | → Outperform | Get Alert |
| 09/06/2022 | TIL | Buy Now | Instil Bio | $28.57 | 8.51% | Jack Allen 37% | $34 → $31 | Maintains | Outperform | Get Alert |
| 06/03/2022 | FATE | Buy Now | Fate Therapeutics | $1.26 | 2122.22% | Jack Allen 37% | → $28 | Initiates | → Neutral | Get Alert |
| 06/03/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 739.69% | Jack Allen 37% | → $11 | Initiates | → Neutral | Get Alert |
| 05/18/2022 | CLLS | Buy Now | Cellectis | $1.41 | — | Jack Allen 37% | — | Upgrade | Neutral → Outperform | Get Alert |
| 03/09/2022 | TSHA | Buy Now | Taysha Gene Therapies | $2.55 | 919.61% | Jack Allen 37% | → $26 | Initiates | → Outperform | Get Alert |
| 12/03/2021 | VOR | Buy Now | Vor Biopharma | $0.22 | 17172.73% | Jack Allen 37% | → $38 | Initiates | → Outperform | Get Alert |
| 11/09/2021 | INKT | Buy Now | MiNK Therapeutics | $7.49 | 247.13% | Jack Allen 37% | → $26 | Initiates | → Outperform | Get Alert |
| 10/22/2021 | DBTX | Buy Now | Decibel Therapeutics | — | — | Jack Allen 37% | → $21 | Initiates | → Outperform | Get Alert |
| 10/08/2021 | CLLS | Buy Now | Cellectis | $1.41 | 609.22% | Jack Allen 37% | $39 → $10 | Downgrade | Outperform → Neutral | Get Alert |
| 10/07/2021 | VYGR | Buy Now | Voyager Therapeutics | $3.10 | 190.32% | Jack Allen 37% | $6 → $9 | Upgrade | Neutral → Outperform | Get Alert |
| 08/13/2021 | TIL | Buy Now | Instil Bio | $28.57 | 19.01% | Jack Allen 37% | → $34 | Initiates | → Outperform | Get Alert |
